Viking Therapeutics Stock Forecast

Stock Price Forecast

According to 14 professional analysts, the 12-month price target for Viking Therapeutics stock ranges from a low of $30 to a high of $125. The average analyst price target of $87.07 forecasts a 125.86% increase in the stock price over the next year.

Price Target: $87.07 (+125.86%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$30	$87.07	$102	$125
Change	-22.18%	+125.86%	+164.59%	+224.25%

Analyst Ratings

The average analyst rating for Viking Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	5	5	6	7	7	7
Buy	6	6	4	5	5	5
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	13	12	14	14	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Edward Nash Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $106 → $107	Strong Buy	Maintains	$106 → $107	+177.56%	Nov 12, 2025
Edward Nash Canaccord Genuity	Canaccord Genuity	Strong Buy Initiates $106	Strong Buy	Initiates	$106	+174.97%	Oct 29, 2025
Hardik Parikh JP Morgan	JP Morgan	Buy Maintains $80 → $75	Buy	Maintains	$80 → $75	+94.55%	Oct 24, 2025
Michael Ulz Morgan Stanley	Morgan Stanley	Buy Maintains $98 → $102	Buy	Maintains	$98 → $102	+164.59%	Oct 23, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $102	Strong Buy	Reiterates	$102	+164.59%	Sep 29, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

7.31M

EPS This Year

-2.71

from -1.01

EPS Next Year

-3.77

from -2.71

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	-	7.31M
Revenue Growth	-	-	-	-	-	-	-
EPS	-0.54	-0.71	-0.90	-0.91	-1.01	-2.71	-3.77
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	19	18

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	n/a	97.9M
Avg	n/a	7.3M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026
High	-2.34	-3.02
Avg	-2.71	-3.77
Low	-2.81	-4.84

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.